In a new report, cannabis industry data and insight firm BDSA estimates that global cannabis sales for 2021 will near $31 billion—an increase of 41% of last year’s sales.
Articles
U.S. House Approves SAFE Banking Act as Part of Military Spending Bill in Historic Vote
The U.S. House approved the Secure and Fair Enforcement Banking Act on Thursday in a bipartisan 316-113 vote as part of the latest National Defense Authorization Act, a military spending bill.
The Mental Health Crisis and Psychedelics: Big Business Targets The Sector
Psychedelic medicine is the solution to the Mental Health Crisis. Psychedelic drugs are a huge commercial opportunity. Big Business moves in.
Mydecine Files MYCO-003 Final Patent Application and Reports Positive Preclinical Data
Mydecine announces filing of patent application for psilocybin-based MYCO-003. Pre-clinical data is showing MYCO-003 to work better than pure psilocybin.
Magic Mushrooms May Be the Biggest Advance in Treating Depression Since Prozac
For most of his adult life, Aaron Presley, age 34, felt like a husk of a person, a piece of "garbage."
Former GOP Congresswoman Touts Psilocybin As Treatment For Alcoholism
A former Republican congresswoman is touting the therapeutic benefits of psychedelics, sharing the story of how a close family friend was able to recover from alcoholism with the help of psilocybin.
Small Pharma Successfully Completes Phase I Clinical Trial Of DMT In Combination With Supportive Psychotherapy
Small Pharma shows DMT to be well-tolerated and safe for the study population as it moves forward toward a Phase IIa clinical trial.
Psyched Wellness Initiates a Clinical Sleep Study on Humans for a Structure/Function Claim For AME-1
Psyched Wellness is preparing for a clinical sleep study for its proprietary extract, AME-1.
The Three Psychedelics ETFs: Which Is The Best Fit For Your Portfolio?
We take a closer look at each of the three psychedelics ETFs and analyze the investment objectives that each ETF addresses.
Italian Referendum To Decriminalize Marijuana, Psilocybin And Other Drug Plants Gets Half A Million Signatures
Activists in Italy say they’ve gathered enough signatures to qualify a ballot measure that would decriminalize personal cultivation and use of not only marijuana but also psilocybin mushrooms and certain other psychoactive plants for personal use.
Florida Advocacy Petition Drive Aims to Allow Home Growing of Cannabis
A political action committee in Florida is spearheading a petition drive to legalize and regulate recreational marijuana in the state, after two previous legalization efforts this year were stymied by the courts.
Study: Synthetic Cannabinoid Users Experience ‘More Severe’ Withdrawal Symptoms
A recent study published in the journal Psychopharmacology suggests that users of synthetic cannabinoid products—such as Spice or K2 —experience more severe withdrawal symptoms than cannabis users, according to an International Business Times outline of the research. It is the first study focused on the long-term and withdrawal effects of using synthetic cannabinoids.
New neuroscience research suggests the cerebral cortex acts as the brain’s hourglass
No one can stay awake forever. While we’re awake, our need for sleep gradually increases.
Missouri Transfers Almost $7M in Cannabis Revenue to Veterans
The Missouri Department of Health and Senior Services said Thursday that it had initiated the second required transfer of revenue from the state’s new medical marijuana program to the Missouri Veterans Commission.
Study on MDMA for Traumatic Brain Injury Boosted By $1.5M Donation
Wesana Health committed to fund a MAPS study on MDMA for traumatic brain injury.